Expression of bone morphogenetic proteins in acute promyelocytic leukemia before and after combined all trans-retinoic acid and cytotoxic treatment

Leuk Res. 2003 Aug;27(8):731-8. doi: 10.1016/s0145-2126(02)00281-3.

Abstract

We investigated the dynamics of bone morphogenetic protein (BMP) and their receptor mRNA expression in relation to combined treatment with all trans-retinoic acid (ATRA) and chemotherapy in four patients with acute promyelocytic leukemia (APL). Reverse transcription-polymerase chain reaction (RT-PCR) analysis of the bone marrow cells at diagnosis showed strong expression of BMP-2, -4, and -7, and their receptors RIA, RIB, and RII, parallel to the expression of promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) fusion gene transcripts. Therapeutic clearance of the tumor molecular marker corresponded to the absence of BMP expression, suggesting the possible role of BMPs as markers of the minimal residual disease (MRD) in APL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers / analysis
  • Bone Marrow Cells / metabolism
  • Bone Marrow Cells / pathology
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Protein 4
  • Bone Morphogenetic Protein 7
  • Bone Morphogenetic Protein Receptors
  • Bone Morphogenetic Protein Receptors, Type I
  • Bone Morphogenetic Protein Receptors, Type II
  • Bone Morphogenetic Proteins / biosynthesis
  • Bone Morphogenetic Proteins / drug effects*
  • Bone Morphogenetic Proteins / genetics
  • Humans
  • Leukemia, Promyelocytic, Acute / diagnosis
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / metabolism
  • Male
  • Middle Aged
  • Neoplasm Proteins / genetics
  • Neoplasm, Residual / diagnosis
  • Oncogene Proteins, Fusion / genetics
  • Protein-Serine-Threonine Kinases / genetics
  • RNA, Messenger / analysis
  • Receptors, Growth Factor / genetics
  • Remission Induction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transforming Growth Factor beta*
  • Tretinoin / administration & dosage*

Substances

  • BMP2 protein, human
  • BMP4 protein, human
  • BMP7 protein, human
  • Biomarkers
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Protein 4
  • Bone Morphogenetic Protein 7
  • Bone Morphogenetic Proteins
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • RNA, Messenger
  • Receptors, Growth Factor
  • Transforming Growth Factor beta
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
  • Tretinoin
  • Protein-Serine-Threonine Kinases
  • BMPR2 protein, human
  • Bone Morphogenetic Protein Receptors
  • Bone Morphogenetic Protein Receptors, Type I
  • Bone Morphogenetic Protein Receptors, Type II